Literature DB >> 3398849

Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11.

P Augereau1, M Garcia, M G Mattei, V Cavailles, F Depadova, D Derocq, F Capony, P Ferrara, H Rochefort.   

Abstract

Two lambda gt11 libraries containing complementary DNAs from human breast cancer MCF7 cells were screened by expression with monoclonal antibodies to the secreted 52K protein and with a 36-mer oligonucleotide derived from the N-terminal amino acid sequence of the secreted 52K protein. Four overlapping clones were sequenced, and found to be extensively homologous to the cathepsin D of normal human kidney, except for 5-point mutations resulting in one amino acid change (Ala to Val) in the profragment of cathepsin D. Northern blot analysis showed the 2.2 kilobase (kb) cathepsin D mRNA to be induced by estradiol in MCF7 cells and produced constitutively at high levels in the estrogen-receptor-negative BT20 cell line. A simple restriction pattern consistent with the restriction map of cathepsin D cDNA was obtained in Southern blot analysis of MCF7 cell DNA. In situ hybridization of the 52K-9 cDNA probe on normal lymphocytes assigned the 52K cathepsin D gene at the extremity of the short arm of chromosome 11, in the p15 band, close to the H-ras gene and in the region whose deletion increases the risk of invasive breast cancer. We conclude that the estrogen induced 52K protein has the same sequence as normal pro-cathepsin D and we propose that the 52K protein correspond to the only pro-cathepsin D expressed in MCF7 cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3398849     DOI: 10.1210/mend-2-2-186

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

1.  Expression and maturation of human cathepsin D in baby-hamster kidney cells.

Authors:  M Horst; A Hasilik
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

2.  Molecular cloning of mouse cathepsin D.

Authors:  M J Grusby; S C Mitchell; L H Glimcher
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

3.  Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma.

Authors:  Xiao-Feng Huang; Chun-Mei Wang; Xiao-Wen Dai; Zhen- Jiang Li; Bo-Rong Pan; Li-Bin Yu; Bin Qian; Li Fang
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

4.  Confirmation of the human cathepsin B gene (CTSB) assignment to chromosome 8.

Authors:  D Fong; M M Chan; W T Hsieh; J C Menninger; D C Ward
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

5.  Modulation of cathepsin D activity in retinal pigment epithelial cells.

Authors:  P E Rakoczy; C M Lai; M Baines; S Di Grandi; J H Fitton; I J Constable
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

6.  Trisomy 21q223 and Down's phenotype correlation evidenced by in situ hybridization.

Authors:  M C Pellissier; M Laffage; N Philip; E Passage; M G Mattei; J F Mattei
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

7.  Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas.

Authors:  D R Welch; S A McClure; P A Aeed; M J Bahner; L D Adams
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

Review 8.  Cathepsin D in breast cancer.

Authors:  H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

Review 9.  Evaluation of cathepsin D as a prognostic factor in breast cancer.

Authors:  P M Ravdin
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells.

Authors:  V Cavaillès; P Augereau; H Rochefort
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.